⌘K

Login Start Free

Home/Filings/4/0001223692-06-000025

4//SEC Filing

AEOLUS PHARMACEUTICALS, INC. 4

Accession 0001223692-06-000025

CIK 0001261734operating

View on SEC.gov Company Profile

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 2:51 PM ET

Size

18.4 KB

Accession

0001223692-06-000025

Insider Transaction Report

Form 4

Period: 2005-12-30

AEOLUS PHARMACEUTICALS, INC.AOLS

Burgoon Richard Jr

Chief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2005-12-30$1.00/sh+20,833$20,833→ 102,582 total
Exercise/Conversion
Common Stock
2006-03-31$1.00/sh+19,760$19,760→ 122,342 total
Exercise/Conversion
Non-Qualified Stock Option
2006-03-31+1,073→ 145,835 total
Exercise: $1.00From: 2005-07-12Exp: 2015-07-12→ Common Stock (1,073 underlying)
Exercise/Conversion
Non-Qualified Stock Option
2006-07-10+20,833→ 125,002 total
Exercise: $1.00From: 2005-07-12Exp: 2015-07-12→ Common Stock (20,833 underlying)
Exercise/Conversion
Incentive Stock Option
2006-03-31+19,760→ 0 total
Exercise: $1.00From: 2005-07-12Exp: 2015-07-12→ Common Stock (19,760 underlying)
Exercise/Conversion
Common Stock
2006-07-10$1.00/sh+20,833$20,833→ 144,248 total
Exercise/Conversion
Common Stock
2006-03-31$1.00/sh+1,073$1,073→ 123,415 total
Exercise/Conversion
Incentive Stock Option
2005-12-30+20,833→ 19,760 total
Exercise: $1.00From: 2005-07-12Exp: 2015-07-12→ Common Stock (20,833 underlying)

Footnotes (1)

[F1]Shares are held in trust by Aeolus Pharmaceuticals, Inc. and not subject to sale by Mr. Burgoon until such time as Mr. Burgoon's position with Aeolus Pharmaceuticals, Inc. has ended, or unless otherwise agreed to by the Board of Directors.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001261734

Filing Metadata

Form type: 4
Filed: Jul 13, 8:00 PM ET
Accepted: Jul 14, 2:51 PM ET
Size: 18.4 KB

View on SEC.gov